Novelcare | Connect your patients to relevant clinical studies in one click

What

Novelcare is a healthcare product that helps providers identify local clinical studies that may be medically relevant for their patients. Its core promise is simple: notify doctors when appropriate research opportunities are available and send study information to the patients the provider identifies as relevant.

The product appears positioned for healthcare providers and trial-participating organizations that want to offer clinical research as a care option without disrupting normal clinical workflow. Based on the page, Novelcare emphasizes patient access to treatment options, operational simplicity, HIPAA-focused trust, and a business model that is free for most practices and may create revenue through chart review for some studies.

Features

• Relevant study matching for providers: Novelcare tells doctors when local clinical studies are available for patients, helping surface research options within routine care.
• One-click patient connection workflow: The product is presented as a fast way to connect patients to studies, reducing manual effort in identifying and sharing research opportunities.
• Automated study information delivery: Novelcare automatically sends study information to patients a provider marks as relevant, which may reduce follow-up burden on staff.
• Clinical workflow preservation: The site states that practices can keep their existing workflow, suggesting the product is designed to fit around current care delivery rather than require major process change.
• No-cost access for most practices: Novelcare says its service is free for most practices, lowering adoption barriers for provider organizations evaluating research referral tools.
• HIPAA and trust emphasis: The company highlights HIPAA compliance, data protection, and contract and operational design centered on patient-data trust.

Helpful Tips

• Validate fit by specialty and geography: Before rollout, confirm that the available studies are relevant to your therapeutic areas and local patient population, since value depends on actual study availability.
• Map referral ownership clearly: Assign responsibility for patient identification, consent-related communication boundaries, and follow-up so research outreach does not become operationally ambiguous.
• Review data-sharing and workflow boundaries carefully: For any clinical-trial referral product, legal, privacy, and operational teams should verify what data is used, when patients are contacted, and how provider oversight is maintained.
• Assess economic value beyond stated free access: If chart-review revenue is part of the model for some studies, evaluate how often that applies and whether it creates meaningful operational return for your practice.
• Pilot with a narrow patient cohort first: A limited rollout can help test provider adoption, patient response, and study relevance before broader implementation.

OpenClaw Skills

Novelcare could likely work well with OpenClaw as part of a clinical research referral and care-navigation workflow. For example, OpenClaw skills could help providers or practice staff triage eligible patients, summarize study relevance by diagnosis or location, draft patient-friendly outreach, and route research opportunities to the right internal team. These are likely use cases rather than confirmed native integrations, since the page does not describe an API or partner ecosystem.

In a broader healthcare operations context, OpenClaw agents built around Novelcare could support referral tracking, chart-review task management, patient follow-up scheduling, and internal reporting on research as a care option. For provider groups, trial sites, or care management teams, that combination could make clinical research outreach more systematic and less dependent on manual coordination, potentially shifting research access from an occasional referral activity to a more operationalized part of patient care.